Therapeutic antibodies for prostate cancer

B Leveugle, D Mann, R Madiyalakan, AA Noujaim

IDrugs, Vol. 3, No. 10, p.1191-1198, 2000

Immunomodulation with antibodies: clinical application in ovarian cancer and other malignancies

CF Nicodemus, BC Schultes, BL Hamilton

Expert Rev. Vaccines, 1(10), 35-48, 2002

Oregovomab

HC Evans, CM Perry

Am. J Cancer, 2(2), 125-133, 2003

Biologic and Immunologic Therapies for Ovarian Cancer

JS Berek, BC Schultes, CF Nicodemus

J Clin Oncol, Vol. 21, No. 10s, 168s-174s, May 2003

Specific Keynote: Immunological Therapy for Ovarian Cancer

JS Berek, O Dorigo, BC Schultes, CF Nicodemus

Gynecologic Oncology, Vol. 88, S105-S109, 2003

Using antibodies in tumor immunotherapy

BC Schultes, CF Nicodemus

Expert Opin. Biol. Ther., 4(8):1265-1284, 2004

Monoclonal antibody therapy of ovarian cancer

CF Nicodemus, JS Berek

Expert Rev. Anticancer Ther. 5(1), 2005

TLR3 agonists as immunotherapeutic agents

CF Nicodemus, JS Berek

Immunotherapy, 2(2), 137-140, 2010

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, A Ocaña, R Leibowitz-Amit, G Sonpavde, JJ Knox, B Tran, IF Tannock, E Amir

J Natl Cancer Inst., 106(6), 2014